Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +50.47%
#3 ApeX ApeX +22.73%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +21.52%
#5 Zora Zora +18.54%
#6 Non-Playable Coin Non-Playable Coin +18.43%
#7 OriginTrail OriginTrail +17.78%
#8 龙虾 (Lobster) 龙虾 (Lobster) +17.65%
#9 Pons Pons +17.55%
#10 Pendle Pendle +15.57%
Coin of the day
Smilek to the Bank Smilek to the Bank
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Classifica tra le azioni #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Prezzo delle azioni
$3.01
Ultima sincronizzazione: 2024-04-12
Capitalizzazione di mercato
$104.64M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Cyteir Therapeutics, Inc. (CYT)

Categoria

Healthcare
Rapporto P/B per Cyteir Therapeutics, Inc. (CYT)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cyteir Therapeutics, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Cyteir Therapeutics, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH